32729234|t|UCHL1 from serum and CSF is a candidate biomarker for amyotrophic lateral sclerosis.
32729234|a|OBJECTIVE: To identify potential ALS biomarkers in patients and to evaluate their diagnostic performance using cerebrospinal fluid (CSF) and serum. METHOD: We recruited a discovery cohort, comprising 20 ALS patients and 20 controls to screen for potential CSF biomarker, UCHL1, using a Luminex neurodegenerative disease panel. To validate UCHL1's diagnostic performance, we used receiver operating characteristic (ROC) curves to determine the potential for early diagnosis in another cohort comprising 23 CSF and 69 serum ALS samples. Finally, we analyzed its correlation with clinical features. RESULTS: We found significantly elevated levels of CSF-derived UCHL1 in both discovery and validation cohorts (P < 0.05). ROC curves revealed an AUC of 0.8288, with a sensitivity and specificity of 73.91% and 81.25%, respectively, when the cut-off value for UCHL1 was >291.9 pg/mL. A similar result was observed in the serum cohort, with the ALS group exhibiting significantly higher serum UCHL1 levels than the controls (P < 0.05). AUC of the ROC in the serum UCHL1 cohort was 0.7709, with sensitivity and specificity of 61.43% and 79.59%, respectively, when the cut-off value of serum UCHL1 was >15.22 pg/mL. At the early stage CSF and serum UCHL1 were significantly different between ALS patients and controls (P < 0.05). Furthermore, serum UCHL1 levels showed a positive relationship with the burden of UMN and LMN dysfunction, albeit with no statistical significance. INTERPRETATION: Taken together, our findings suggest that ALS patients exhibit significantly elevated CSF- and serum-derived UCHL1. Moreover, our data warrant that UCHL1 displays good diagnostic performance and provide novel options for ALS early diagnosis. However, its prognostic value needs to be further investigated.
32729234	0	5	UCHL1	Gene	7345
32729234	54	83	amyotrophic lateral sclerosis	Disease	MESH:D000690
32729234	118	121	ALS	Disease	MESH:D008113
32729234	136	144	patients	Species	9606
32729234	288	291	ALS	Disease	MESH:D008113
32729234	292	300	patients	Species	9606
32729234	356	361	UCHL1	Gene	7345
32729234	379	404	neurodegenerative disease	Disease	MESH:D019636
32729234	424	429	UCHL1	Gene	7345
32729234	607	610	ALS	Disease	MESH:D008113
32729234	744	749	UCHL1	Gene	7345
32729234	939	944	UCHL1	Gene	7345
32729234	1023	1026	ALS	Disease	MESH:D008113
32729234	1071	1076	UCHL1	Gene	7345
32729234	1142	1147	UCHL1	Gene	7345
32729234	1268	1273	UCHL1	Gene	7345
32729234	1325	1330	UCHL1	Gene	7345
32729234	1368	1371	ALS	Disease	MESH:D008113
32729234	1372	1380	patients	Species	9606
32729234	1425	1430	UCHL1	Gene	7345
32729234	1488	1491	UMN	Disease	
32729234	1496	1511	LMN dysfunction	Disease	MESH:D006331
32729234	1612	1615	ALS	Disease	MESH:D008113
32729234	1616	1624	patients	Species	9606
32729234	1679	1684	UCHL1	Gene	7345
32729234	1718	1723	UCHL1	Gene	7345
32729234	1791	1794	ALS	Disease	MESH:D008113
32729234	Association	MESH:D006331	7345
32729234	Association	MESH:D000690	7345
32729234	Positive_Correlation	MESH:D008113	7345

